TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 390528

Group type: EXPERIMENTAL
Intervention: 25 mg of atenolol daily
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 100 mg of atenolol daily
Number of subjects: 5

Group type: COMPARATOR
Intervention: 0 mg of atenolol daily (control)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atenolol (various doses)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atenolol (25 mg daily)
Number of subjects: 5
Study: 30201237

Group type: EXPERIMENTAL
Intervention: Morphine plus ketamine (0.1 mg/kg morphine plus 0.2 mg/kg ketamine)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Morphine plus placebo (0.1 mg/kg morphine plus normal saline)
Number of subjects: 200
Study: 29206237

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Calorie Restricted Diet (CRD)
Number of subjects: 66
Study: 25781440

Group type: EXPERIMENTAL
Intervention: Continued thienopyridine for 18 months after 12 months of DAPT
Number of subjects: 11648

Group type: COMPARATOR
Intervention: Placebo for 18 months after 12 months of DAPT
Number of subjects: 11648

Group type: EXPERIMENTAL
Intervention: Continued thienopyridine for 18 months after 12 months of DAPT (all patients)
Number of subjects: 11648

Group type: COMPARATOR
Intervention: Placebo for 18 months after 12 months of DAPT (all patients)
Number of subjects: 11648
Study: 23872799

Group type: EXPERIMENTAL
Intervention: IV pamidronate (1 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21769048

Group type: EXPERIMENTAL
Intervention: Citicoline (500 mg twice daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 19254614

Group type: EXPERIMENTAL
Intervention: Walking with a walking cane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ankle foot orthosis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Slider shoe
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of all 3 devices
Number of subjects: 20

Group type: COMPARATOR
Intervention: Walking with no device (control condition)
Number of subjects: 20
Study: 18645758

Group type: EXPERIMENTAL
Intervention: Intensive Quality Assurance (IQA) training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Workshop Only (WSO)
Number of subjects: 70
Study: 15106798

Group type: EXPERIMENTAL
Intervention: Baseline daytime ambulatory blood pressure
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Follow-up clinic blood pressure after 6 months
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Normal systolic daytime ambulatory blood pressure at baseline
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Normal follow-up clinic blood pressure
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Incidence of cardiovascular events
Number of subjects: 295
Study: 11771971

Group type: EXPERIMENTAL
Intervention: 20 mg paroxetine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 60 mg paroxetine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 9640900

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention program for parents (manual-guided program during the first six months following diagnosis)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 81
Study: 7857486

Group type: EXPERIMENTAL
Intervention: TRAVELPILOT IDS navigation system
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional road map
Number of subjects: 48
Study: 2492744

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (74 mumol.kg‐1.d‐1) during 11 postoperative days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Carnitine-free total parenteral nutrition (TPN)
Number of subjects: 16
Study: 982547

Group type: EXPERIMENTAL
Intervention: Suramin (4-6 g)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Suramin followed by diethylcarbamazine (6-7 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 96
Study: 11561266

Group type: EXPERIMENTAL
Intervention: 5 mL of mepivacaine (Group I)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 10 mL of mepivacaine (Group II)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 5 mL twice with an interval of 5 minutes (Group III)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 5 mL twice with an interval of 10 minutes (Group IV)
Number of subjects: 89
Study: 30667591

Group type: EXPERIMENTAL
Intervention: Once-daily extended-release tacrolimus tablets (LCPT) 0.07-0.13 mg/kg/day
Number of subjects: 58

Group type: COMPARATOR
Intervention: Twice-daily immediate-release tacrolimus capsules (IR-Tac) 0.10-0.15 mg/kg/day
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Once-daily extended-release tacrolimus tablets (LCPT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Twice-daily immediate-release tacrolimus capsules (IR-Tac)
Number of subjects: 58
Study: 30413507

Group type: EXPERIMENTAL
Intervention: Digital treatment programme (Joint Academy) for 3 months
Number of subjects: 270

Group type: COMPARATOR
Intervention: Standard treatment (BOA) for 3 months
Number of subjects: 270
Study: 27387703

Group type: EXPERIMENTAL
Intervention: +0.300 μm spherical aberration
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: +0.150 μm spherical aberration
Number of subjects: 10

Group type: COMPARATOR
Intervention: Negative spherical aberration
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control condition (no SA induction)
Number of subjects: 10
Study: 25191967

Group type: EXPERIMENTAL
Intervention: Methacholine (MCh) challenge with deep inspirations (DIs) taken immediately after the last dose
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Methacholine (MCh) challenge with DIs taken 30 minutes after the last dose
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ex vivo assessment of airway smooth muscle (ASM) shortening during a progressive decrease of carbachol concentration
Number of subjects: 5
Study: 22718089

Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 vaccine (200 μg dose)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 vaccine (60 μg dose)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 vaccine (20 μg dose)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 vaccine
Number of subjects: 99

Group type: COMPARATOR
Intervention: hepatitis A vaccine/placebo control
Number of subjects: 99
Study: 20584541

Group type: EXPERIMENTAL
Intervention: Patient Self Management (PSM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Patient Self Testing (PST)
Number of subjects: 28
Study: 17368623

Group type: EXPERIMENTAL
Intervention: Gefitinib (250 mg/day orally)
Number of subjects: 21
Study: 16149143

Group type: EXPERIMENTAL
Intervention: High-dose interferon-α2b (10 MU daily for 3 weeks, then 5 MU/TIW) plus ribavirin (1,000-1,200 mg/d) for 21 weeks, continued until week 48 if negative HCV RNA PCR.
Number of subjects: 70
Study: 12195931

Group type: EXPERIMENTAL
Intervention: 7.5 mg THC
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 15 mg THC
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9469743

Group type: EXPERIMENTAL
Intervention: Nasal-airway volume (measured by acoustic rhinometry)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Body temperature
Number of subjects: 0
Study: 7703820

Group type: EXPERIMENTAL
Intervention: Individual treatment for partners of drinkers
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Group treatment for partners of drinkers
Number of subjects: 23

Group type: COMPARATOR
Intervention: No-treatment waiting list control
Number of subjects: 23
Study: 2469579

Group type: EXPERIMENTAL
Intervention: ZK 36374 (prostacyclin analogue)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: ZK 36374
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Gamma camera and whole body monitor
Number of subjects: 32
Study: 786665

Group type: EXPERIMENTAL
Intervention: Acetylcysteine 600 mg daily, 3 days a week for 6 months
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 31995214

Group type: EXPERIMENTAL
Intervention: Behavioral health‐virtual patient navigation program (video contact in ED and telephonic outreach 24 to 72 hours after discharge, then weekly for up to 45 days)
Number of subjects: 637

Group type: COMPARATOR
Intervention: Usual care (no virtual patient navigation program)
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Behavioral health‐virtual patient navigation program
Number of subjects: 637

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 637
Study: 30696474

Group type: EXPERIMENTAL
Intervention: Moderate to light sedation target (Richmond Agitation-Sedation Scale of -3 to 0)
Number of subjects: 5719

Group type: EXPERIMENTAL
Intervention: Board-certified intensivists on morning and afternoon shifts
Number of subjects: 5719

Group type: EXPERIMENTAL
Intervention: Target sedation levels
Number of subjects: 5719
Study: 27633813

Group type: EXPERIMENTAL
Intervention: Anterior turbinoplasty (ATP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Submucous radial diode laser ablation (DLA)
Number of subjects: 60
Study: 26782852

Group type: EXPERIMENTAL
Intervention: High-intensity functional exercise program
Number of subjects: 186

Group type: COMPARATOR
Intervention: Seated control activity
Number of subjects: 186
Study: 25052850

Group type: EXPERIMENTAL
Intervention: Home-based counselling intervention by trained volunteers
Number of subjects: 5240
Study: 22594305

Group type: EXPERIMENTAL
Intervention: Rabeprazole sodium (20 mg daily) for 4 weeks
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: PPI-resistant LPRD patients
Number of subjects: 350

Group type: COMPARATOR
Intervention: Healthy controls matched for age and sex
Number of subjects: 350
Study: 19383241

Group type: EXPERIMENTAL
Intervention: Sinus rhythm control with aspirin (group 1)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Sinus rhythm control with warfarin (group 2)
Number of subjects: 534

Group type: COMPARATOR
Intervention: Ventricular rate control (group 3)
Number of subjects: 534
Study: 17447980

Group type: EXPERIMENTAL
Intervention: 5% calcipotriol cream
Number of subjects: 27

Group type: COMPARATOR
Intervention: Moisturizing cream
Number of subjects: 27
Study: 15135698

Group type: EXPERIMENTAL
Intervention: Achieved HR at rest (quartiles: 44 to 69, 70 to 78, 79 to 87, 88 to 148 beats/min)
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Achieved exercise HR (quartiles: 53 to 82, 83 to 92, 93 to 106, 107 to 220 beats/min)
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Achieved HR at rest
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Achieved exercise HR
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Achieved HR
Number of subjects: 680
Study: 11322197

Group type: EXPERIMENTAL
Intervention: 400 kcal liquid meal
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 9142342

Group type: EXPERIMENTAL
Intervention: Surgical release
Number of subjects: 2

Group type: COMPARATOR
Intervention: Long-term hemodialysis
Number of subjects: 2

Group type: COMPARATOR
Intervention: Idiopathic carpal tunnel syndrome
Number of subjects: 2
Study: 8203766

Group type: EXPERIMENTAL
Intervention: EGb 761 (320 mg per day for four weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2954005

Group type: EXPERIMENTAL
Intervention: IFN alpha-2C
Number of subjects: 102

Group type: COMPARATOR
Intervention: IFN alpha-2C plus medroxyprogesteroneacetate
Number of subjects: 102
Study: 29633328

Group type: EXPERIMENTAL
Intervention: Group training using the Otago Exercise Programme
Number of subjects: 728

Group type: COMPARATOR
Intervention: Individual training using the Otago Exercise Programme
Number of subjects: 728
Study: 28903476

Group type: EXPERIMENTAL
Intervention: AdVEGF‐DΔNΔC gene therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study: 27442387

Group type: EXPERIMENTAL
Intervention: Psycho-education
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group without psycho-education
Number of subjects: 64
Study: 23187147

Group type: EXPERIMENTAL
Intervention: Air puffs + blinking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air puffs without instruction to blink
Number of subjects: 0

Group type: COMPARATOR
Intervention: No air puffs
Number of subjects: 0
Study: 21691281

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (ART)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Observation plus selective salvage radiotherapy (SRT)
Number of subjects: 100
Study: 18335068

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 335

Group type: COMPARATOR
Intervention: Praziquantel
Number of subjects: 335
Study: 16551821

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia with terminal warm blood cardioplegia (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cold blood cardioplegia (Group A)
Number of subjects: 40
Study: 12589843

Group type: EXPERIMENTAL
Intervention: ME inflation for 10 days
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: ME inflation and antibiotics (oral Amoxicillin 500 mg 3/day) for 10 days
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 198
Study: 10752495

Group type: EXPERIMENTAL
Intervention: Cockcroft formula (Clcr = ((140 - age) x body weight)/(72 x Scr), x 0.85 for females)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Six equations and one nomogram
Number of subjects: 38
Study: 9113191

Group type: EXPERIMENTAL
Intervention: Ketamine 50 mg x 4 per day dissolved in juice
Number of subjects: 1

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 1
Study: 8272492

Group type: EXPERIMENTAL
Intervention: EMLA cream 5% applied for 15 to 30 minutes
Number of subjects: 13
Study: 3476505

Group type: COMPARATOR
Intervention: 150 micrograms/ml sanguinaria and 0.2% zinc chloride (Rinse B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 300 micrograms/ml sanguinaria and no zinc chloride (Rinse C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 300 micrograms/ml sanguinaria and 0.2% zinc chloride (Rinse D)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo oral rinse (Rinse A)
Number of subjects: 0
Study: 29443994

Group type: EXPERIMENTAL
Intervention: Coherent light control via feedback-based wavefront shaping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random quasi-phase-matching (QPM) scheme
Number of subjects: 0
Study: 26474111

Group type: EXPERIMENTAL
Intervention: Recruitment maneuver with V(RM) calculated by integrating the flow-time waveform during a 30-second breath hold at 40 cm H2O airway pressure
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Recruitment maneuver with low V(RM)
Number of subjects: 42
Study: 25002717

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Guideline-based usual care (UC)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Adherent patients (≥ 90 minutes per week)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nonadherent patients (< 90 minutes per week)
Number of subjects: 90
Study: 21968596

Group type: EXPERIMENTAL
Intervention: 3T (triple target treatment)
Number of subjects: 158

Group type: COMPARATOR
Intervention: EMG-BF (electromyography biofeedback)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: 3T
Number of subjects: 158
Study: 20555284

Group type: EXPERIMENTAL
Intervention: Whole-body compression garments (WBCGs)
Number of subjects: 8
Study: 18477086

Group type: EXPERIMENTAL
Intervention: Ropivacaine 10 mg/ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Levobupivacaine 7.5 mg/ml
Number of subjects: 40
Study: 15713943

Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg daily)
Number of subjects: 2586

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2586

Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 2586
Study: 12066676

Group type: EXPERIMENTAL
Intervention: Sonic toothbrush
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mechanical toothbrush
Number of subjects: 8

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 8
Study: 9851651

Group type: EXPERIMENTAL
Intervention: Gabapentin 500 mg/day for 6 months (Group A)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Gabapentin 1000 mg/day for 6 months (Group B)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Gabapentin 500 mg/day for 6 months followed by 1000 mg/day for 6 months (Group C)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (Group D) receiving only symptomatic treatment
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Gabapentin (all groups)
Number of subjects: 110
Study: 7925878

Group type: EXPERIMENTAL
Intervention: Acetylcholine sweat-spot test (0.1 of 1% acetylcholine intradermally injected into the dorsum of the feet)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Acetylcholine sweat-spot test
Number of subjects: 35
Study: 2529986

Group type: EXPERIMENTAL
Intervention: Selenium supplement (150 micrograms/d for 21 days)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (glucose)
Number of subjects: 38
Study: 1092531

Group type: EXPERIMENTAL
Intervention: Nebulized isoproterenol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 6104295

Group type: EXPERIMENTAL
Intervention: Trimazosin (TMZ) treatment for up to 52 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 28278597

Group type: EXPERIMENTAL
Intervention: Digital measurement feedback system (MFS) and brief consultation supports
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Digital measurement feedback system (MFS)
Number of subjects: 14
Study: 28651590

Group type: EXPERIMENTAL
Intervention: Temporal corneal incision
Number of subjects: 100

Group type: COMPARATOR
Intervention: Superior corneal incision
Number of subjects: 100
Study: 26786567

Group type: EXPERIMENTAL
Intervention: 0.5% C. indicum water extract cosmetic cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (no extract) cosmetic cream
Number of subjects: 0
Study: 25180636

Group type: EXPERIMENTAL
Intervention: Collagen implant with gentamicin sulphate (Collatamp(®))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22577263

Group type: EXPERIMENTAL
Intervention: Topical tacrolimus monotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Emollient-only maintenance
Number of subjects: 68
Study: 19535545

Group type: EXPERIMENTAL
Intervention: Professional development in scientifically based reading instruction (35-hour course on phonemic awareness, phonics, and fluency; coaching for one year)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no professional development)
Number of subjects: 47
Study: 17633971

Group type: EXPERIMENTAL
Intervention: 5 mg zoledronic acid annually
Number of subjects: 7765

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7765
Study: 14737746

Group type: EXPERIMENTAL
Intervention: 120-microg pramlintide injected at 0 min
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 120-microg pramlintide injected at -15, +15, and +30 min
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo injected at -15 min
Number of subjects: 19
Study: 11786572

Group type: EXPERIMENTAL
Intervention: G-CSF (lenograstim) 5 microg/kg/d from day 7 until ANC > or = 500/microL sustained over 48 hours after two induction courses.
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (no G-CSF).
Number of subjects: 148
Study: 9885888

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ceftazidim plus gentamicin (CAZ/GM)
Number of subjects: 18
Study: 8016006

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2656769

Group type: EXPERIMENTAL
Intervention: 0.4% SnF2
Number of subjects: 61

Group type: COMPARATOR
Intervention: 0.22% NaF
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 61
Study: 30927000

Group type: EXPERIMENTAL
Intervention: Healthful Plant-Based Diet Index (hPDI)
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Unhealthful Plant-Based Diet Index (uPDI)
Number of subjects: 831
Study: 28384675

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3 mg
Number of subjects: 1767

Group type: COMPARATOR
Intervention: Sham/Laser
Number of subjects: 1767
Study: 26138423

Group type: EXPERIMENTAL
Intervention: Invasive‐noninvasive sequential mechanical ventilation (MV)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (MV)
Number of subjects: 91
Study: 23598734

Group type: EXPERIMENTAL
Intervention: Balanced anesthesia maintained with isoflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol
Number of subjects: 30
Study: 21225563

Group type: EXPERIMENTAL
Intervention: Dinoprostone vaginal insert retained for 12 to 24 hours
Number of subjects: 431
Study: 19192028

Group type: EXPERIMENTAL
Intervention: Walnut meal
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Almond meal
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control meal (smoothies)
Number of subjects: 13
Study: 15896827

Group type: EXPERIMENTAL
Intervention: valsartan 80 mg/day for 8 weeks
Number of subjects: 53
Study: 14998786

Group type: EXPERIMENTAL
Intervention: Arginine boluses (1-60 mg/kg) injected intravenously at 29-min intervals for 120 min
Number of subjects: 10

Group type: COMPARATOR
Intervention: Basal state (no intervention)
Number of subjects: 10
Study: 11156653

Group type: EXPERIMENTAL
Intervention: Various interventions for IBS (specific interventions not detailed in the abstract)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future trials should include well-defined outcome measures and quality of life measures.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future trials should be double blinded and placebo controlled.
Number of subjects: 0
Study: 9629649

Group type: EXPERIMENTAL
Intervention: Proschan and Hunsberger method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bauer and Kohne method
Number of subjects: 0